SAKAR HEALTHCARE
|
SAKAR HEALTHCARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 13.70 | 7.97 | 5.37 | 6.70 | 8.87 |
| CEPS(Rs) | 24.29 | 17.49 | 13.67 | 14.57 | 14.52 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 145.82 | 128.75 | 118.41 | 91.04 | 74.45 |
| Tax Rate(%) | 23.32 | 18.70 | 26.60 | 24.91 | 19.82 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 27.53 | 27.99 | 25.03 | 24.94 | 22.88 |
| EBIT Margin(%) | 19.07 | 16.94 | 15.33 | 17.21 | 17.03 |
| Pre Tax Margin(%) | 15.79 | 12.12 | 10.37 | 12.74 | 14.76 |
| PAT Margin (%) | 12.11 | 9.86 | 7.61 | 9.57 | 11.84 |
| Cash Profit Margin (%) | 21.47 | 21.61 | 19.38 | 20.80 | 19.38 |
| Performance Ratios | |||||
| ROA(%) | 6.80 | 4.35 | 3.22 | 4.22 | 6.81 |
| ROE(%) | 10.04 | 6.48 | 5.42 | 8.48 | 13.44 |
| ROCE(%) | 12.52 | 8.43 | 7.42 | 8.95 | 12.09 |
| Asset Turnover(x) | 0.56 | 0.44 | 0.42 | 0.44 | 0.58 |
| Sales/Fixed Asset(x) | 0.62 | 0.47 | 0.45 | 0.49 | 0.79 |
| Working Capital/Sales(x) | 8.14 | 6.95 | 12.22 | 93.66 | 39.47 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.62 | 2.13 | 2.20 | 2.03 | 1.27 |
| Receivable days | 58.58 | 53.06 | 51.16 | 49.62 | 37.80 |
| Inventory Days | 82.38 | 73.30 | 51.33 | 40.48 | 42.53 |
| Payable days | 107.49 | 107.64 | 116.77 | 140.43 | 123.30 |
| Valuation Parameters | |||||
| PER(x) | 36.38 | 26.55 | 68.64 | 29.94 | 15.24 |
| PCE(x) | 20.52 | 12.11 | 26.95 | 13.77 | 9.31 |
| Price/Book(x) | 3.42 | 1.64 | 3.11 | 2.20 | 1.82 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 4.68 | 3.10 | 5.74 | 3.76 | 2.53 |
| EV/Core EBITDA(x) | 16.48 | 10.80 | 21.17 | 13.21 | 10.29 |
| EV/EBIT(x) | 24.56 | 18.31 | 37.42 | 21.83 | 14.84 |
| EV/CE(x) | 2.99 | 1.48 | 2.58 | 1.71 | 1.21 |
| M Cap / Sales | 4.41 | 2.62 | 5.22 | 2.86 | 1.80 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 41.76 | 15.80 | 14.99 | 4.00 | 35.35 |
| Core EBITDA Growth(%) | 40.32 | 22.73 | 9.56 | 20.41 | 32.47 |
| EBIT Growth(%) | 59.63 | 27.92 | 2.45 | 5.09 | 38.88 |
| PAT Growth(%) | 74.18 | 49.96 | -8.53 | -15.95 | 42.10 |
| EPS Growth(%) | 71.83 | 48.59 | -19.92 | -24.44 | 29.65 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.22 | 0.31 | 0.31 | 0.69 | 0.73 |
| Current Ratio(x) | 1.28 | 1.40 | 1.21 | 1.03 | 1.07 |
| Quick Ratio(x) | 0.64 | 0.71 | 0.74 | 0.74 | 0.77 |
| Interest Cover(x) | 5.81 | 3.52 | 3.09 | 3.85 | 7.51 |
| Total Debt/Mcap(x) | 0.06 | 0.19 | 0.10 | 0.31 | 0.40 |
Compare Financial Ratios of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,975.4 Cr | -7.5% | -25.1% | 169.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -7.5% |
-25.1% |
169.7% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses
